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Case Presentation:
Trigeminal Trophic Syndrome
History of Present Illness: A 50 year old Caucasian male presented with 
an approximate 4 month history of left sided facial pruritus and paresthesias that 
started 2 weeks following an ischemic stroke with subsequent unilateral facial ulcers. 
He reported regularly picking and scratching the affected areas. According to MRI 
results at the time, the left cerebellum and medulla were affected in the region of the 
left vertebral basilar artery. Patient reported mild motor dysfunction and paresthesias 
on the right side of his body.
Medical History/Surgical History: Hypertension, hyperlipidemia, chronic 
back/neck pain, finger surgery
Family History: Father hypertension
Medications: Aspirin, metoprolol, pravastatin, lorazepam, tramadol
Current Treatment: Mupirocin ointment, petrolatum, benzoyl peroxide wash
Physical Examination: Well dermaracted angulated crusted ulcers located on 
the left ala, cutaneous upper lip, medial cheek, forehead, and scalp. There is scarring 
alopecia of the left frontal scalp with milia. Diminished tactile sensation of the left 
side of face in the V1 and V2 distribution of the trigeminal nerve is appreciated.
Laboratory Data: Gram stain, AFB, and fungal stains all negative
Biopsy: Advanced Dermatology Associates, Ltd. (AD13-00946, 1/22/2013) Left 
nasolabial fold: “Ulceration with fibrosis and inflammation.”
Discussion:
 Trigeminal trophic syndrome (TTS) is a rare syndrome characterized by the triad of trigeminal anesthesia, facial paresthesia, and 
ulceration of the lateral nasal ala “ulceration en arc.” This condition was originally described by Wallenberg in 1901. Peripheral or 
central injury to the trigeminal sensory nuclei or spinal trigeminal tract, ganglion, or peripheral nerve branches is thought to be the 
underlying pathogenesis. The most common cause is from sequelae following treatment for trigeminal neuralgia including alcohol 
injection, rhizotomy of the sensory component of the trigeminal nerve, or destruction of the Gasserian ganglion. An important 
central cause is cerebrovascular accident representing approximately 33% of cases.
 Patients typically present with unilateral facial ulceration of the nasal ala with less common involvement of the lip, cheek, jaw, 
temple, forehead and scalp. Interestingly, the nasal tip is spared as its innervation is via the anterior ethmoidal nerve branch of the 
ophthalmic division of the trigeminal nerve. The ulcerations are self-induced and prompted by ongoing paresthesia and anesthesia. 
The ulcers have been reported to develop from 2 weeks up to 30 years following the inciting injury.  
 Histopathological findings of the ulcerations are non-specific and consist of an ulcer with lymphohistiocytic infiltrate without 
vasculitis, neoplasia or infection. Thus, the diagnosis of TTS is clinical in nature. Differential diagnoses for a non-healing facial ulcer 
include basal cell carcinoma, squamous cell carcinoma, syphilis, leprosy, yaws, mycobacterial, fungal or parasitic infections, T-cell 
lymphoma, Wegener’s granulomatosis or pyoderma gangrenosum.
 Treatment for trigeminal trophic syndrome is multifaceted and involves treatment of underlying paresthesias, behavior 
modification for prevention of self induced injury and if severe enough surgical intervention. Educating the patient on their 
primary role in the pathogenesis of this disorder is paramount. Self-mutilation may be discouraged through the use of protective 
gloves and protective dressings such as hydrocolloid or alginate preparations with adjunctive topical lidocaine. Another topical 
preparation that has shown success is trolamine/sodium alginate containing emulsion.  Wound infection may be prevented with 
topical antibiotics. Medical treatments used with various success include carbamazepine, amitriptyline, pregabilin, gabapentin and 
pimozide. Less commonly, surgical reconstruction and transcutaneous electrical nerve stimulation may be used as treatment.  
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Figure 1a: Multiple ulcers on the scalp with evidence of milia and scarring alopecia
Figure 1b: Irregular angulated ulcers of the nasal ala, cutaneous upper lip and medial cheek.  Note the classic sparing of the nasal tip
Figure 2: Histopathology showing ulceration with fibrosis and inflammation
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